UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Developing an Evidence-Based Epilepsy Risk Assessment eHealth Solution: From Concept to Market

Newman, C; Shankar, R; Hanna, J; McLean, B; Osland, A; Milligan, C; Ball, A; ... Walker, M; + view all (2016) Developing an Evidence-Based Epilepsy Risk Assessment eHealth Solution: From Concept to Market. JMIR Research Protocols , 5 (2) , Article e82. 10.2196/resprot.5389. Green open access

[thumbnail of Walker_fc-xsltGalley-5389-83362-12-PB.pdf]
Preview
Text
Walker_fc-xsltGalley-5389-83362-12-PB.pdf - Published Version

Download (507kB) | Preview

Abstract

INTRODUCTION: Sudden unexpected death in epilepsy (SUDEP) is possibly the most common cause of death as a result of complications from epilepsy. The need to educate and regularly review risk for all patients with epilepsy is paramount, but rarely delivered in actual clinical practice. Evidence suggests that education around SUDEP and modifiable risk variables translate into better self-management of epilepsy. OBJECTIVE: We aimed to develop and implement an eHealth solution to support education and self-management of risks, in epilepsy. METHODS: We undertook an innovation pathways approach, including problem identification, feasibility assessment, design, implementation, and marketing. People with epilepsy were provided a smartphone-based app (Epilepsy Self-Monitor, EpSMon), which translates the clinical risk assessment tool into an educational and self-monitoring platform, for the self-management of epilepsy. RESULTS: Results include the success of the marketing campaign, and in what areas, with an estimated reach of approximately 38 million people. EpSMon has proved a success in academic and clinical circles, attracting awards and nominations for awards. The number of users of EpSMon, after 3 months, turned out to be lower than expected (N=221). A 4-month trial of the app in use in the United Kingdom, and the success of the marketing strategy, point to necessary changes to the model of delivery and marketing, summarized in this paper. These include the marketing message, user cost model, and need for the availability of an Android version. CONCLUSIONS: EpSMon has proven a success in respect to its reception by academics, clinicians, stakeholder groups, and the patients who use it. There is work needed to promote the model and increase its acceptability/attractiveness, including broadening the marketing message, increasing its availability, and reducing its cost. Future development and promotion of the tool will hopefully inform iterative design of its core features for a receptive audience and lead to increased uptake as it is launched worldwide in 2016.

Type: Article
Title: Developing an Evidence-Based Epilepsy Risk Assessment eHealth Solution: From Concept to Market
Open access status: An open access version is available from UCL Discovery
DOI: 10.2196/resprot.5389
Language: English
Additional information: The work is licensed under the Creative Commons Attribution License CC-BY 2.0
Keywords: eHealth; mhealth; mobile app; epilepsy; SUDEP; self-management; self-monitoring; smartphone
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology > Clinical and Experimental Epilepsy
URI: https://discovery.ucl.ac.uk/id/eprint/1501222
Downloads since deposit
134Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item